Parent Project Muscular Dystrophy: Leading the fight to end Duchenne: "PPMD is happy to be supporting Summit PLC with its utrophin upregulation drug candidate SMT C1100. The funding provided will enable Summit to manufacture a new formulation of SMT C1100 and conduct a Phase I clinical trial in healthy volunteers."
'via Blog this'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment